drugset
drugset / Trial / NCT03859921

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

NCT03859921 ↗

Phase 3 Recruiting 716 enrolled The University of Hong Kong
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.

Timeline

Start
2021-07-01
Primary completion
2025-12-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg Oral

Indications

infertility disorder